Gerstein Fisher’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Gerstein Fisher’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,624	Closed	-$799K	–	441
2015 Q1	$799K	Buy	4,624 +105	+2%	+$15.4K	0.13%	153
2014 Q4	$519K	Sell	4,519 -99	-2%	-$12K	0.08%	211
2014 Q3	$722K	Buy	4,618 +26	+0.6%	+$3.77K	0.13%	156
2014 Q2	$566K	Buy	4,592 +28	+0.6%	+$3.1K	0.11%	162
2014 Q1	$473K	Buy	4,564 +3,791	+490%	+$388K	0.09%	179
2013 Q4	$695K	Buy	+773	New	+$61.7K	0.03%	345

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Gerstein Fisher's SLXP Position: Q2 2015 in Review

Gerstein Fisher sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 4,624 shares — an estimated $799K sold.

Gerstein Fisher first reported a position in SLXP in Q4 2013 and held it in 6 quarters. The position peaked at $799K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Gerstein Fisher reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Gerstein Fisher sold 4,624 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $799K.
Gerstein Fisher first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2013 and held it in 6 quarters.
Gerstein Fisher's SALIX PHARMACEUTICALS LTD DEL position peaked at $799K in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Gerstein Fisher's 13F filing for Q2 2015, filed 13 Aug 2015.